nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisapride—CYP2C19—coronary artery disease	0.137	0.552	CbGaD
Cisapride—HTR2A—coronary artery disease	0.111	0.448	CbGaD
Cisapride—CYP2C8—Fenofibrate—coronary artery disease	0.0186	0.0317	CbGbCtD
Cisapride—CYP2B6—Clopidogrel—coronary artery disease	0.017	0.029	CbGbCtD
Cisapride—CYP3A7—Eplerenone—coronary artery disease	0.0166	0.0283	CbGbCtD
Cisapride—CYP3A7-CYP3A51P—Eplerenone—coronary artery disease	0.0166	0.0283	CbGbCtD
Cisapride—CYP2C8—Gemfibrozil—coronary artery disease	0.0148	0.0253	CbGbCtD
Cisapride—CYP3A5—Clopidogrel—coronary artery disease	0.0134	0.0228	CbGbCtD
Cisapride—CYP2C9—Fenofibrate—coronary artery disease	0.0129	0.0221	CbGbCtD
Cisapride—CYP2C8—Clopidogrel—coronary artery disease	0.0129	0.0219	CbGbCtD
Cisapride—KCNH2—purkinje fiber—coronary artery disease	0.0127	0.225	CbGeAlD
Cisapride—CYP2C19—Gemfibrozil—coronary artery disease	0.0125	0.0212	CbGbCtD
Cisapride—CYP3A5—Eplerenone—coronary artery disease	0.0124	0.0212	CbGbCtD
Cisapride—CYP1A2—Gemfibrozil—coronary artery disease	0.0115	0.0196	CbGbCtD
Cisapride—CYP2C8—Pitavastatin—coronary artery disease	0.0112	0.0192	CbGbCtD
Cisapride—CYP2C19—Clopidogrel—coronary artery disease	0.0108	0.0184	CbGbCtD
Cisapride—CYP3A7-CYP3A51P—Simvastatin—coronary artery disease	0.0107	0.0182	CbGbCtD
Cisapride—CYP3A7—Simvastatin—coronary artery disease	0.0107	0.0182	CbGbCtD
Cisapride—CYP3A7—Lovastatin—coronary artery disease	0.0105	0.0178	CbGbCtD
Cisapride—CYP3A7-CYP3A51P—Lovastatin—coronary artery disease	0.0105	0.0178	CbGbCtD
Cisapride—CYP2C9—Gemfibrozil—coronary artery disease	0.0104	0.0177	CbGbCtD
Cisapride—CYP2B6—Simvastatin—coronary artery disease	0.0102	0.0174	CbGbCtD
Cisapride—CYP1A2—Clopidogrel—coronary artery disease	0.00996	0.017	CbGbCtD
Cisapride—CYP3A7—Atorvastatin—coronary artery disease	0.00953	0.0162	CbGbCtD
Cisapride—CYP3A7-CYP3A51P—Atorvastatin—coronary artery disease	0.00953	0.0162	CbGbCtD
Cisapride—CYP2C19—Telmisartan—coronary artery disease	0.00944	0.0161	CbGbCtD
Cisapride—CYP2B6—Atorvastatin—coronary artery disease	0.00907	0.0155	CbGbCtD
Cisapride—CYP2C9—Clopidogrel—coronary artery disease	0.00898	0.0153	CbGbCtD
Cisapride—CYP3A5—Rosuvastatin—coronary artery disease	0.00862	0.0147	CbGbCtD
Cisapride—CYP3A4—Ticagrelor—coronary artery disease	0.00845	0.0144	CbGbCtD
Cisapride—HTR2B—cardial valve—coronary artery disease	0.00823	0.146	CbGeAlD
Cisapride—CYP2C8—Acetylsalicylic acid—coronary artery disease	0.00808	0.0138	CbGbCtD
Cisapride—CYP3A5—Simvastatin—coronary artery disease	0.00802	0.0137	CbGbCtD
Cisapride—CYP3A5—Lovastatin—coronary artery disease	0.00785	0.0134	CbGbCtD
Cisapride—CYP3A5—Pravastatin—coronary artery disease	0.00785	0.0134	CbGbCtD
Cisapride—CYP2C9—Pitavastatin—coronary artery disease	0.00785	0.0134	CbGbCtD
Cisapride—CYP2C8—Simvastatin—coronary artery disease	0.00771	0.0131	CbGbCtD
Cisapride—CYP2C9—Valsartan—coronary artery disease	0.00763	0.013	CbGbCtD
Cisapride—CYP2C19—Timolol—coronary artery disease	0.00761	0.013	CbGbCtD
Cisapride—CYP2C8—Pravastatin—coronary artery disease	0.00754	0.0129	CbGbCtD
Cisapride—CYP2C8—Lovastatin—coronary artery disease	0.00754	0.0129	CbGbCtD
Cisapride—CYP3A4—Fenofibrate—coronary artery disease	0.00753	0.0128	CbGbCtD
Cisapride—CYP3A5—Atorvastatin—coronary artery disease	0.00715	0.0122	CbGbCtD
Cisapride—CYP2C19—Rosuvastatin—coronary artery disease	0.00696	0.0119	CbGbCtD
Cisapride—CYP2C8—Atorvastatin—coronary artery disease	0.00687	0.0117	CbGbCtD
Cisapride—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.00678	0.0116	CbGbCtD
Cisapride—KCNH2—endocardium—coronary artery disease	0.00657	0.116	CbGeAlD
Cisapride—CYP3A5—Losartan—coronary artery disease	0.00654	0.0111	CbGbCtD
Cisapride—CYP2C19—Simvastatin—coronary artery disease	0.00647	0.011	CbGbCtD
Cisapride—CYP2C19—Lovastatin—coronary artery disease	0.00633	0.0108	CbGbCtD
Cisapride—CYP2C8—Losartan—coronary artery disease	0.00628	0.0107	CbGbCtD
Cisapride—CYP2D6—Niacin—coronary artery disease	0.00622	0.0106	CbGbCtD
Cisapride—CYP3A4—Gemfibrozil—coronary artery disease	0.00602	0.0103	CbGbCtD
Cisapride—CYP2C9—Rosuvastatin—coronary artery disease	0.00578	0.00986	CbGbCtD
Cisapride—CYP2D6—Timolol—coronary artery disease	0.00578	0.00986	CbGbCtD
Cisapride—CYP2C19—Atorvastatin—coronary artery disease	0.00576	0.00983	CbGbCtD
Cisapride—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00564	0.00961	CbGbCtD
Cisapride—CYP2C9—Simvastatin—coronary artery disease	0.00538	0.00917	CbGbCtD
Cisapride—CYP2C9—cardial valve—coronary artery disease	0.00534	0.0944	CbGeAlD
Cisapride—CYP2C19—Losartan—coronary artery disease	0.00527	0.00899	CbGbCtD
Cisapride—CYP2C9—Pravastatin—coronary artery disease	0.00526	0.00897	CbGbCtD
Cisapride—CYP2C9—Lovastatin—coronary artery disease	0.00526	0.00897	CbGbCtD
Cisapride—CYP3A4—Clopidogrel—coronary artery disease	0.00522	0.0089	CbGbCtD
Cisapride—CYP2D6—Captopril—coronary artery disease	0.00509	0.00868	CbGbCtD
Cisapride—CYP2D6—Simvastatin—coronary artery disease	0.00492	0.00839	CbGbCtD
Cisapride—CYP1A2—Losartan—coronary artery disease	0.00486	0.0083	CbGbCtD
Cisapride—CYP3A4—Eplerenone—coronary artery disease	0.00485	0.00827	CbGbCtD
Cisapride—CYP2D6—Lovastatin—coronary artery disease	0.00481	0.00821	CbGbCtD
Cisapride—CYP2D6—Pravastatin—coronary artery disease	0.00481	0.00821	CbGbCtD
Cisapride—CYP2C9—Atorvastatin—coronary artery disease	0.00479	0.00817	CbGbCtD
Cisapride—CYP2C9—Losartan—coronary artery disease	0.00438	0.00748	CbGbCtD
Cisapride—CYP2D6—Atorvastatin—coronary artery disease	0.00438	0.00747	CbGbCtD
Cisapride—CYP3A4—Enalapril—coronary artery disease	0.00432	0.00737	CbGbCtD
Cisapride—HTR3A—vagus nerve—coronary artery disease	0.00415	0.0735	CbGeAlD
Cisapride—CYP3A4—Rosuvastatin—coronary artery disease	0.00336	0.00574	CbGbCtD
Cisapride—CYP3A4—Ezetimibe—coronary artery disease	0.00336	0.00574	CbGbCtD
Cisapride—CYP3A4—Simvastatin—coronary artery disease	0.00313	0.00533	CbGbCtD
Cisapride—CYP3A4—Pravastatin—coronary artery disease	0.00306	0.00522	CbGbCtD
Cisapride—CYP3A4—Lovastatin—coronary artery disease	0.00306	0.00522	CbGbCtD
Cisapride—CYP3A4—Atorvastatin—coronary artery disease	0.00279	0.00475	CbGbCtD
Cisapride—HTR2A—arteriole—coronary artery disease	0.00272	0.048	CbGeAlD
Cisapride—CYP3A4—Losartan—coronary artery disease	0.00255	0.00435	CbGbCtD
Cisapride—HTR2A—pulmonary artery—coronary artery disease	0.00178	0.0315	CbGeAlD
Cisapride—HTR2A—sympathetic nervous system—coronary artery disease	0.00173	0.0306	CbGeAlD
Cisapride—HTR2A—vagus nerve—coronary artery disease	0.00168	0.0296	CbGeAlD
Cisapride—HTR2A—vein—coronary artery disease	0.00162	0.0286	CbGeAlD
Cisapride—Metoclopramide—CYP11B2—coronary artery disease	0.00157	0.589	CrCbGaD
Cisapride—HTR2A—autonomic nervous system—coronary artery disease	0.00116	0.0206	CbGeAlD
Cisapride—HTR2A—artery—coronary artery disease	0.000659	0.0117	CbGeAlD
Cisapride—HTR2A—endothelium—coronary artery disease	0.000557	0.00986	CbGeAlD
Cisapride—KCNH2—cardiac ventricle—coronary artery disease	0.000553	0.00978	CbGeAlD
Cisapride—KCNH2—myocardium—coronary artery disease	0.00052	0.0092	CbGeAlD
Cisapride—Iloperidone—HTR7—coronary artery disease	0.0005	0.187	CrCbGaD
Cisapride—HTR2B—heart—coronary artery disease	0.000455	0.00805	CbGeAlD
Cisapride—HTR3A—blood—coronary artery disease	0.000449	0.00795	CbGeAlD
Cisapride—HTR2B—cardiovascular system—coronary artery disease	0.000429	0.00759	CbGeAlD
Cisapride—KCNH2—heart—coronary artery disease	0.000363	0.00642	CbGeAlD
Cisapride—KCNH2—cardiovascular system—coronary artery disease	0.000342	0.00606	CbGeAlD
Cisapride—HTR2B—blood—coronary artery disease	0.000339	0.006	CbGeAlD
Cisapride—KCNH2—cardiac atrium—coronary artery disease	0.00031	0.00549	CbGeAlD
Cisapride—CYP2B6—heart—coronary artery disease	0.000298	0.00527	CbGeAlD
Cisapride—CYP2C9—heart—coronary artery disease	0.000295	0.00522	CbGeAlD
Cisapride—CYP2C19—blood—coronary artery disease	0.000284	0.00502	CbGeAlD
Cisapride—CYP2B6—cardiovascular system—coronary artery disease	0.000281	0.00497	CbGeAlD
Cisapride—CYP2C9—cardiovascular system—coronary artery disease	0.000278	0.00492	CbGeAlD
Cisapride—KCNH2—blood—coronary artery disease	0.000271	0.00479	CbGeAlD
Cisapride—Iloperidone—HTR2A—coronary artery disease	0.000251	0.094	CrCbGaD
Cisapride—CYP2C8—blood—coronary artery disease	0.000248	0.00438	CbGeAlD
Cisapride—HTR2A—heart—coronary artery disease	0.000243	0.0043	CbGeAlD
Cisapride—CYP1A2—blood—coronary artery disease	0.000232	0.0041	CbGeAlD
Cisapride—HTR2A—cardiovascular system—coronary artery disease	0.000229	0.00405	CbGeAlD
Cisapride—CYP3A5—blood—coronary artery disease	0.000224	0.00396	CbGeAlD
Cisapride—Gefitinib—CYP2C19—coronary artery disease	0.000223	0.0835	CrCbGaD
Cisapride—CYP2B6—blood—coronary artery disease	0.000222	0.00393	CbGeAlD
Cisapride—CYP2C9—blood—coronary artery disease	0.00022	0.00389	CbGeAlD
Cisapride—HTR2A—blood—coronary artery disease	0.000181	0.00321	CbGeAlD
Cisapride—CYP3A4—blood—coronary artery disease	0.000168	0.00297	CbGeAlD
Cisapride—CYP2D6—blood—coronary artery disease	0.000165	0.00292	CbGeAlD
Cisapride—Gefitinib—ALB—coronary artery disease	0.000124	0.0463	CrCbGaD
Cisapride—CYP3A7—Metabolism—PTGS2—coronary artery disease	2.26e-06	2.13e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—F2—coronary artery disease	2.25e-06	2.13e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—FN1—coronary artery disease	2.25e-06	2.13e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PLCB1—coronary artery disease	2.25e-06	2.13e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—IL6ST—coronary artery disease	2.24e-06	2.12e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—GSTP1—coronary artery disease	2.24e-06	2.12e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—GSTM1—coronary artery disease	2.24e-06	2.12e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—NFKBIA—coronary artery disease	2.22e-06	2.1e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—ALDH2—coronary artery disease	2.22e-06	2.1e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—GSTP1—coronary artery disease	2.22e-06	2.1e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	2.22e-06	2.1e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—MTHFR—coronary artery disease	2.21e-06	2.09e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—HMOX1—coronary artery disease	2.21e-06	2.09e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	2.2e-06	2.09e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	2.2e-06	2.08e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—LPL—coronary artery disease	2.19e-06	2.08e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—KIT—coronary artery disease	2.19e-06	2.07e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—HMOX1—coronary artery disease	2.19e-06	2.07e-05	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—AKT1—coronary artery disease	2.19e-06	2.07e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—ABCA1—coronary artery disease	2.18e-06	2.06e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—CAT—coronary artery disease	2.18e-06	2.06e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—CASP3—coronary artery disease	2.17e-06	2.05e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—LIPC—coronary artery disease	2.16e-06	2.05e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—CYP2C19—coronary artery disease	2.16e-06	2.05e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—HBA1—coronary artery disease	2.16e-06	2.05e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	2.16e-06	2.05e-05	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—PIK3CA—coronary artery disease	2.16e-06	2.04e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—CAT—coronary artery disease	2.16e-06	2.04e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—SERPINE1—coronary artery disease	2.16e-06	2.04e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—KIT—coronary artery disease	2.15e-06	2.04e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—IL6—coronary artery disease	2.15e-06	2.04e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—APOC3—coronary artery disease	2.15e-06	2.03e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—GPX1—coronary artery disease	2.14e-06	2.03e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—LDLR—coronary artery disease	2.14e-06	2.02e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PPARG—coronary artery disease	2.12e-06	2.01e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—APOB—coronary artery disease	2.11e-06	2e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—SLC9A1—coronary artery disease	2.11e-06	2e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—GSTT1—coronary artery disease	2.11e-06	2e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—GGT1—coronary artery disease	2.11e-06	2e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—GOT1—coronary artery disease	2.11e-06	2e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—CCND1—coronary artery disease	2.11e-06	2e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—AGT—coronary artery disease	2.1e-06	1.99e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—GSK3B—coronary artery disease	2.1e-06	1.99e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—APOB—coronary artery disease	2.1e-06	1.98e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—POMC—coronary artery disease	2.09e-06	1.98e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—FGF2—coronary artery disease	2.09e-06	1.97e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—GCLC—coronary artery disease	2.09e-06	1.97e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—CETP—coronary artery disease	2.09e-06	1.97e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—CD36—coronary artery disease	2.08e-06	1.97e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—POMC—coronary artery disease	2.08e-06	1.97e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CREB1—coronary artery disease	2.08e-06	1.97e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PPARG—coronary artery disease	2.07e-06	1.96e-05	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—PTGS2—coronary artery disease	2.07e-06	1.96e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—GSK3B—coronary artery disease	2.07e-06	1.96e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—SDC1—coronary artery disease	2.06e-06	1.95e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—APOE—coronary artery disease	2.06e-06	1.95e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PPP2CA—coronary artery disease	2.06e-06	1.95e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—NOS3—coronary artery disease	2.06e-06	1.95e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—GSTM1—coronary artery disease	2.06e-06	1.95e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—POMC—coronary artery disease	2.05e-06	1.94e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CREB1—coronary artery disease	2.05e-06	1.94e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—MMP9—coronary artery disease	2.05e-06	1.94e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—POMC—coronary artery disease	2.04e-06	1.93e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—GSTM1—coronary artery disease	2.04e-06	1.93e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CCL2—coronary artery disease	2.04e-06	1.93e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—APOA1—coronary artery disease	2.04e-06	1.93e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—IL6R—coronary artery disease	2.03e-06	1.92e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—LPL—coronary artery disease	2.02e-06	1.91e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CCL2—coronary artery disease	2.01e-06	1.9e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—IGF1—coronary artery disease	2e-06	1.9e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—LPL—coronary artery disease	2e-06	1.89e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—JAK2—coronary artery disease	2e-06	1.89e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—IL6R—coronary artery disease	2e-06	1.89e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—MAPK1—coronary artery disease	1.99e-06	1.89e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—AKT1—coronary artery disease	1.99e-06	1.88e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—MTHFR—coronary artery disease	1.98e-06	1.87e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—IGF1—coronary artery disease	1.97e-06	1.87e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—GPX1—coronary artery disease	1.97e-06	1.86e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—MAPK1—coronary artery disease	1.96e-06	1.86e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—PIK3CA—coronary artery disease	1.96e-06	1.86e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—GPX1—coronary artery disease	1.95e-06	1.85e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.95e-06	1.85e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PSMB5—coronary artery disease	1.95e-06	1.84e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PSMA6—coronary artery disease	1.95e-06	1.84e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—CD36—coronary artery disease	1.92e-06	1.81e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—ALB—coronary artery disease	1.91e-06	1.8e-05	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—PIK3CA—coronary artery disease	1.91e-06	1.8e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—CTGF—coronary artery disease	1.9e-06	1.8e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—SERPINE1—coronary artery disease	1.9e-06	1.8e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—CD36—coronary artery disease	1.9e-06	1.8e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—GSTP1—coronary artery disease	1.9e-06	1.79e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PPP2CA—coronary artery disease	1.89e-06	1.79e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—HMGCR—coronary artery disease	1.89e-06	1.79e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—GOT2—coronary artery disease	1.89e-06	1.79e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	1.88e-06	1.78e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PPP2CA—coronary artery disease	1.88e-06	1.78e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—AGT—coronary artery disease	1.88e-06	1.78e-05	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—PIK3CA—coronary artery disease	1.88e-06	1.77e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—SERPINE1—coronary artery disease	1.87e-06	1.77e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—HMOX1—coronary artery disease	1.87e-06	1.77e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—ALB—coronary artery disease	1.86e-06	1.76e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—CAT—coronary artery disease	1.84e-06	1.75e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—FGF2—coronary artery disease	1.84e-06	1.74e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—APOE—coronary artery disease	1.84e-06	1.74e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—VEGFA—coronary artery disease	1.84e-06	1.74e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CXCL8—coronary artery disease	1.83e-06	1.73e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—NOS3—coronary artery disease	1.82e-06	1.73e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—APOA1—coronary artery disease	1.82e-06	1.72e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—MTHFR—coronary artery disease	1.82e-06	1.72e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—NOS3—coronary artery disease	1.82e-06	1.72e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—FGF2—coronary artery disease	1.81e-06	1.71e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—MTHFR—coronary artery disease	1.8e-06	1.7e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PPARG—coronary artery disease	1.79e-06	1.7e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—APOB—coronary artery disease	1.79e-06	1.69e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—NOS3—coronary artery disease	1.79e-06	1.69e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—NOS3—coronary artery disease	1.78e-06	1.69e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—POMC—coronary artery disease	1.77e-06	1.67e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—JAK2—coronary artery disease	1.77e-06	1.67e-05	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—AKT1—coronary artery disease	1.76e-06	1.67e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CASP3—coronary artery disease	1.75e-06	1.65e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—GSTM1—coronary artery disease	1.74e-06	1.65e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.74e-06	1.65e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—JAK2—coronary artery disease	1.74e-06	1.64e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—IL6—coronary artery disease	1.74e-06	1.64e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PLCB1—coronary artery disease	1.73e-06	1.64e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—PIK3CA—coronary artery disease	1.73e-06	1.64e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—AGT—coronary artery disease	1.73e-06	1.63e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—AGT—coronary artery disease	1.71e-06	1.62e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—LPL—coronary artery disease	1.71e-06	1.62e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—PIK3CA—coronary artery disease	1.7e-06	1.61e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CCND1—coronary artery disease	1.7e-06	1.61e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—APOE—coronary artery disease	1.69e-06	1.6e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—TGFB1—coronary artery disease	1.69e-06	1.6e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—ABCA1—coronary artery disease	1.68e-06	1.59e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—APOE—coronary artery disease	1.68e-06	1.59e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—APOA1—coronary artery disease	1.67e-06	1.58e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—GPX1—coronary artery disease	1.67e-06	1.58e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PTGS2—coronary artery disease	1.67e-06	1.58e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—APOA1—coronary artery disease	1.66e-06	1.57e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—MAPK1—coronary artery disease	1.65e-06	1.57e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—MMP9—coronary artery disease	1.65e-06	1.56e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PTGS2—coronary artery disease	1.63e-06	1.54e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—GGT1—coronary artery disease	1.63e-06	1.54e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—GOT1—coronary artery disease	1.63e-06	1.54e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—CD36—coronary artery disease	1.62e-06	1.54e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—ALB—coronary artery disease	1.61e-06	1.53e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CXCL8—coronary artery disease	1.61e-06	1.52e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PPP2CA—coronary artery disease	1.6e-06	1.52e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PPARG—coronary artery disease	1.6e-06	1.52e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—AKT1—coronary artery disease	1.6e-06	1.52e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.59e-06	1.5e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CXCL8—coronary artery disease	1.59e-06	1.5e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—POMC—coronary artery disease	1.58e-06	1.49e-05	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—AKT1—coronary artery disease	1.56e-06	1.47e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—NOS3—coronary artery disease	1.54e-06	1.46e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CASP3—coronary artery disease	1.54e-06	1.46e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—MTHFR—coronary artery disease	1.54e-06	1.46e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—IL6—coronary artery disease	1.53e-06	1.45e-05	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—AKT1—coronary artery disease	1.53e-06	1.45e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CASP3—coronary artery disease	1.52e-06	1.44e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—IL6—coronary artery disease	1.51e-06	1.43e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CCND1—coronary artery disease	1.5e-06	1.42e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—VEGFA—coronary artery disease	1.48e-06	1.4e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CCND1—coronary artery disease	1.48e-06	1.4e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PPARG—coronary artery disease	1.47e-06	1.39e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—GSTP1—coronary artery disease	1.46e-06	1.38e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—AGT—coronary artery disease	1.46e-06	1.38e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PPARG—coronary artery disease	1.46e-06	1.38e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—MMP9—coronary artery disease	1.46e-06	1.38e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—POMC—coronary artery disease	1.45e-06	1.38e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	1.45e-06	1.37e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.44e-06	1.37e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—POMC—coronary artery disease	1.44e-06	1.36e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—ALB—coronary artery disease	1.44e-06	1.36e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—PIK3CA—coronary artery disease	1.44e-06	1.36e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—MMP9—coronary artery disease	1.43e-06	1.36e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—APOE—coronary artery disease	1.43e-06	1.36e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—CAT—coronary artery disease	1.42e-06	1.35e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—APOA1—coronary artery disease	1.42e-06	1.34e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—AKT1—coronary artery disease	1.41e-06	1.34e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PTGS2—coronary artery disease	1.41e-06	1.34e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—AKT1—coronary artery disease	1.39e-06	1.32e-05	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—PIK3CA—coronary artery disease	1.39e-06	1.31e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—APOB—coronary artery disease	1.38e-06	1.31e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—NOS3—coronary artery disease	1.38e-06	1.3e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—TGFB1—coronary artery disease	1.36e-06	1.29e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.36e-06	1.28e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.34e-06	1.27e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—MAPK1—coronary artery disease	1.33e-06	1.26e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—ALB—coronary artery disease	1.32e-06	1.25e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—LPL—coronary artery disease	1.32e-06	1.25e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—ALB—coronary artery disease	1.31e-06	1.24e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—VEGFA—coronary artery disease	1.31e-06	1.24e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—VEGFA—coronary artery disease	1.29e-06	1.22e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—GPX1—coronary artery disease	1.29e-06	1.22e-05	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—PIK3CA—coronary artery disease	1.27e-06	1.2e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—IL6—coronary artery disease	1.27e-06	1.2e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—NOS3—coronary artery disease	1.27e-06	1.2e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PTGS2—coronary artery disease	1.26e-06	1.19e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—NOS3—coronary artery disease	1.26e-06	1.19e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—CD36—coronary artery disease	1.25e-06	1.19e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PPARG—coronary artery disease	1.25e-06	1.18e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.24e-06	1.17e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—POMC—coronary artery disease	1.23e-06	1.16e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—TGFB1—coronary artery disease	1.2e-06	1.14e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.19e-06	1.12e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—TGFB1—coronary artery disease	1.18e-06	1.12e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—MAPK1—coronary artery disease	1.18e-06	1.11e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—AKT1—coronary artery disease	1.17e-06	1.11e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—MAPK1—coronary artery disease	1.16e-06	1.1e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PTGS2—coronary artery disease	1.16e-06	1.1e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—PIK3CA—coronary artery disease	1.16e-06	1.1e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PTGS2—coronary artery disease	1.15e-06	1.09e-05	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—AKT1—coronary artery disease	1.13e-06	1.07e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—AGT—coronary artery disease	1.13e-06	1.07e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—ALB—coronary artery disease	1.12e-06	1.06e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—APOE—coronary artery disease	1.11e-06	1.05e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—APOA1—coronary artery disease	1.09e-06	1.03e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—NOS3—coronary artery disease	1.07e-06	1.02e-05	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—AKT1—coronary artery disease	1.04e-06	9.83e-06	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PIK3CA—coronary artery disease	1.03e-06	9.71e-06	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—IL6—coronary artery disease	1.03e-06	9.7e-06	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—PIK3CA—coronary artery disease	1.02e-06	9.67e-06	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—PIK3CA—coronary artery disease	1.01e-06	9.52e-06	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PIK3CA—coronary artery disease	1e-06	9.49e-06	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PTGS2—coronary artery disease	9.82e-07	9.29e-06	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PPARG—coronary artery disease	9.63e-07	9.12e-06	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—POMC—coronary artery disease	9.5e-07	8.99e-06	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—AKT1—coronary artery disease	9.46e-07	8.95e-06	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—IL6—coronary artery disease	9.05e-07	8.56e-06	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—IL6—coronary artery disease	8.91e-07	8.43e-06	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PIK3CA—coronary artery disease	8.69e-07	8.22e-06	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—ALB—coronary artery disease	8.66e-07	8.2e-06	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—AKT1—coronary artery disease	8.38e-07	7.93e-06	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—AKT1—coronary artery disease	8.35e-07	7.9e-06	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—NOS3—coronary artery disease	8.29e-07	7.84e-06	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—AKT1—coronary artery disease	8.22e-07	7.77e-06	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—AKT1—coronary artery disease	8.19e-07	7.75e-06	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PIK3CA—coronary artery disease	7.75e-07	7.34e-06	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PTGS2—coronary artery disease	7.58e-07	7.17e-06	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PIK3CA—coronary artery disease	7.13e-07	6.75e-06	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—AKT1—coronary artery disease	7.1e-07	6.71e-06	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PIK3CA—coronary artery disease	7.07e-07	6.69e-06	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—AKT1—coronary artery disease	6.33e-07	5.99e-06	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PIK3CA—coronary artery disease	6.04e-07	5.72e-06	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—AKT1—coronary artery disease	5.83e-07	5.51e-06	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—AKT1—coronary artery disease	5.78e-07	5.46e-06	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—AKT1—coronary artery disease	4.94e-07	4.67e-06	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PIK3CA—coronary artery disease	4.66e-07	4.41e-06	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—AKT1—coronary artery disease	3.81e-07	3.6e-06	CbGpPWpGaD
